444 related articles for article (PubMed ID: 12694176)
1. Antisense technologies. Improvement through novel chemical modifications.
Kurreck J
Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
[TBL] [Abstract][Full Text] [Related]
2. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
3. Antisense technology: a selective tool for gene expression regulation and gene targeting.
Sahu NK; Shilakari G; Nayak A; Kohli DV
Curr Pharm Biotechnol; 2007 Oct; 8(5):291-304. PubMed ID: 17979727
[TBL] [Abstract][Full Text] [Related]
4. Strategies to identify potential therapeutic target sites in RNA.
Lützelberger M; Kjems J
Handb Exp Pharmacol; 2006; (173):243-59. PubMed ID: 16594619
[TBL] [Abstract][Full Text] [Related]
5. Development of antisense oligodeoxynucleotides for transplantation.
Stepkowski SM
Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
[TBL] [Abstract][Full Text] [Related]
6. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
Jen KY; Gewirtz AM
Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.
Grünweller A; Wyszko E; Bieber B; Jahnel R; Erdmann VA; Kurreck J
Nucleic Acids Res; 2003 Jun; 31(12):3185-93. PubMed ID: 12799446
[TBL] [Abstract][Full Text] [Related]
9. The versatility of oligonucleotides as potential therapeutics.
Eckstein F
Expert Opin Biol Ther; 2007 Jul; 7(7):1021-34. PubMed ID: 17665991
[TBL] [Abstract][Full Text] [Related]
10. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
[TBL] [Abstract][Full Text] [Related]
11. Properties of circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides.
Park WS; Miyano-Kurosaki N; Abe T; Takai K; Takaku H
Nucleic Acids Symp Ser; 1999; (42):225-6. PubMed ID: 10780461
[TBL] [Abstract][Full Text] [Related]
12. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
13. RNA therapeutics: beyond RNA interference and antisense oligonucleotides.
Kole R; Krainer AR; Altman S
Nat Rev Drug Discov; 2012 Jan; 11(2):125-40. PubMed ID: 22262036
[TBL] [Abstract][Full Text] [Related]
14. Antisense DNA and RNA agents against picornaviruses.
Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D
Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540
[TBL] [Abstract][Full Text] [Related]
15. Approaches for the sequence-specific knockdown of mRNA.
Scherer LJ; Rossi JJ
Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligodeoxynucleotide and ribozyme design.
Probst JC
Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
[TBL] [Abstract][Full Text] [Related]
17. [Prospects of antisense therapy technologies].
Skoblov MIu
Mol Biol (Mosk); 2009; 43(6):984-98. PubMed ID: 20088374
[TBL] [Abstract][Full Text] [Related]
18. Generation and application of asymmetric hammerhead ribozymes.
Hammann C; Tabler M
Methods; 1999 Jul; 18(3):273-80. PubMed ID: 10454985
[TBL] [Abstract][Full Text] [Related]
19. Prospects for antiviral ribozymes and deoxyribozymes.
Peracchi A
Rev Med Virol; 2004; 14(1):47-64. PubMed ID: 14716691
[TBL] [Abstract][Full Text] [Related]
20. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
